Available ZIOPTAN (TM) (tafluprost ophthalmic solution) 0.0015% from Merck. Find out more today at zioptan.com.
Click here to view this e-mail in a browser.
Conference Brief
OphthalmologyTimes.com

DAY 3 - Monday, Nov. 12

Welcome

Ophthalmology Times welcomes ophthalmic professionals from around the world to Chicago. Our four-day coverage of this year’s meeting of the American Academy of Ophthalmology begins today and includes the latest research findings and clinical news of interest to readers.
Enjoy the meeting!


Section Head 1

Headline 1

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation. » MORE

Headline 2

Article summary/teaser copy goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation. » MORE


Section Head 2

Headline 3

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation. » MORE

Headline 4

Article summary/teaser copy goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation. » MORE


Section Head 3

Headline 5

Article summary/teaser copy goes here. Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation. » MORE


DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
Available ZIOPTAN (TM) (tafluprost ophthalmic solution) 0.0015% from Merck. Find out more today at zioptan.com.

We welcome your feedback!
Please send your comments to:

Mark L. Dlugoss

Editor-in-Chief

Advanstar Eye Health Group

mdlugoss@advanstar.com

 

You are subscribed to [xxx] as [xxx]. Click here to unsubscribe or edit your member profile.

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.